Principal Financial Group Inc. trimmed its position in Xylem Inc. (NYSE:XYL - Free Report) by 8.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 290,876 shares of the industrial products company's stock after selling 27,440 shares during the period. Principal Financial Group Inc. owned approximately 0.12% of Xylem worth $39,277,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. EverSource Wealth Advisors LLC increased its position in Xylem by 68.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company's stock worth $25,000 after purchasing an additional 77 shares in the last quarter. Bangor Savings Bank lifted its holdings in Xylem by 56.7% in the 3rd quarter. Bangor Savings Bank now owns 235 shares of the industrial products company's stock worth $32,000 after purchasing an additional 85 shares in the last quarter. Mark Sheptoff Financial Planning LLC bought a new stake in shares of Xylem during the second quarter valued at approximately $33,000. Blue Trust Inc. increased its holdings in Xylem by 1,185.7% in the 2nd quarter. Blue Trust Inc. now owns 270 shares of the industrial products company's stock worth $35,000 after buying an additional 249 shares during the period. Finally, Catalyst Capital Advisors LLC lifted its stake in shares of Xylem by 226.0% in the third quarter. Catalyst Capital Advisors LLC now owns 339 shares of the industrial products company's stock worth $46,000 after buying an additional 235 shares in the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.
Xylem Stock Up 0.3 %
Shares of Xylem stock traded up $0.34 during midday trading on Tuesday, hitting $124.97. The company had a trading volume of 1,524,302 shares, compared to its average volume of 1,193,394. Xylem Inc. has a 52-week low of $98.21 and a 52-week high of $146.08. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.42 and a current ratio of 1.96. The company has a 50 day moving average of $131.21 and a 200 day moving average of $134.99. The stock has a market capitalization of $30.36 billion, a P/E ratio of 36.64, a P/E/G ratio of 2.29 and a beta of 1.05.
Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, meeting analysts' consensus estimates of $1.11. The company had revenue of $2.10 billion for the quarter, compared to the consensus estimate of $2.17 billion. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The firm's revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter last year, the company earned $0.99 earnings per share. On average, equities analysts predict that Xylem Inc. will post 4.23 earnings per share for the current fiscal year.
Xylem Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, September 26th. Investors of record on Thursday, August 29th were given a dividend of $0.36 per share. The ex-dividend date was Thursday, August 29th. This represents a $1.44 dividend on an annualized basis and a yield of 1.15%. Xylem's dividend payout ratio (DPR) is 42.11%.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on XYL shares. Robert W. Baird reduced their price objective on Xylem from $175.00 to $154.00 and set an "outperform" rating for the company in a research report on Friday, November 1st. Royal Bank of Canada dropped their price objective on Xylem from $163.00 to $162.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. Stifel Nicolaus upped their target price on Xylem from $170.00 to $172.00 and gave the stock a "buy" rating in a report on Wednesday, July 31st. TD Cowen dropped their price objective on Xylem from $138.00 to $125.00 and set a "hold" rating on the stock in a research note on Wednesday, November 6th. Finally, UBS Group started coverage on shares of Xylem in a report on Tuesday, August 13th. They set a "buy" rating and a $165.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $147.17.
Read Our Latest Research Report on XYL
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Articles
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.